Celator Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/16 Q1

ended 12/31/15 FY 2015

ended 09/30/15 Q3

ended 06/30/15 Q2

ended 03/31/15 Q1

Prospectuses and Registrations Filter

Securities registration termination – amended

Updated info for already-effective prospectus

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Ownership Filter

Thomas, McNerney & Partners II L.P.

Quaker Bio Ventures LP

Ridgeback Capital Investments L.P.

Kollender Richard S

News Filter

Jazz Pharmaceuticals Plc Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stock of Celator Pharmaceuticals, Inc

Pharmaceuticals® Announces Positive Results in Patients With FLT3 Mutation From the Phase 3 Trial in High-Risk Acute Myeloid Leukemia

Pharmaceuticals® Presented Phase 3 Trial Results in Patients With High-Risk Acute Myeloid Leukemia Demonstrating VYXEOS™ (CPX-351) Significantly Improved Overall Survival

Jazz Pharmaceuticals and Celator Pharmaceuticals Announce Agreement for Jazz Pharmaceuticals to Acquire Celator for $30.25 Per Share

Material Definitive Agreement, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Confidential treatment order

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC